These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 7614506)

  • 21. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibitors in heart failure: new strategies justified by recent clinical trials.
    Young JB
    Int J Cardiol; 1994 Feb; 43(2):151-63. PubMed ID: 8181869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice.
    Mendelson G; Aronow WS
    J Am Geriatr Soc; 1998 Jun; 46(6):751-2. PubMed ID: 9625192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure.
    Manohar P; Piña IL
    Mayo Clin Proc; 2003 Mar; 78(3):334-8. PubMed ID: 12630586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of intervention with losartan or captopril in acute myocardial infarction.
    Spinar J; Vitovec J; Spinarova L; Pluhacek L; Fischerova B; Toman J
    Eur J Heart Fail; 2000 Mar; 2(1):91-100. PubMed ID: 10742708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.
    Andersson F; Cline C; Rydén-Bergsten T; Erhardt L
    Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
    Lombardi WL; Litwin SE
    Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic treatment of heart failure with standard drugs.
    Pitt B
    Curr Opin Cardiol; 1994 May; 9(3):289-94. PubMed ID: 8049587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of congestive heart failure by ACE inhibition in patients with acute myocardial infarction.
    Sigurdsson A; Swedberg K
    J Cardiovasc Risk; 1995 Oct; 2(5):406-12. PubMed ID: 8749267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
    Doggrell SA
    Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction.
    LeJemtel TH; Hochman JS; Sonnenblick EH
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):47S-51S. PubMed ID: 7775715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE inhibitors in congestive heart failure.
    Riegger AJ
    Cardiology; 1989; 76 Suppl 2():42-9. PubMed ID: 2670220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do ACE inhibitors provide protection for the heart in the clinical setting of acute myocardial infarction?
    Megarry SG; Sapsford R; Hall AS; Ball SG
    Drugs; 1997; 54 Suppl 5():48-58. PubMed ID: 9429845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction?
    Nelson KM; Yeager BF
    Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
    Rangaswamy C; Finn JI; Koelling TM
    Cardiology; 2005; 103(1):17-23. PubMed ID: 15528896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications for ACE inhibitors in the postinfarct period].
    Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K
    Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle.
    Simko F; Simko J; Fabryova M
    Cardiovasc Drugs Ther; 2003 May; 17(3):287-90. PubMed ID: 14669746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current controversies with ACE inhibitor treatment in heart failure.
    Visser FC; Visser CA
    Cardiology; 1996; 87 Suppl 1():23-8. PubMed ID: 8681318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
    Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.